PBIO OTC
Pressure BioSciences, Inc.
1W: +0.0%
1M: -50.0%
3M: -71.4%
YTD: -60.0%
1Y: -60.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
+14.4% ▲
5Y CAGR: -4.3%
Gross Profit
$800K
+380.9% ▲
5Y CAGR: -7.5%
Operating Income
-$10M
-94.0% ▼
Net Income
-$29M
-82.3% ▼
EPS (Diluted)
$-1.51
+6.2% ▲
EBITDA
-$9M
-73.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $2M | $1M | $2M | $2M | $2M |
| YoY Growth | -26.4% | -32.6% | +64.0% | -13.6% | +14.4% |
| Cost of Revenue | $1M | $583K | $942K | $2M | $1M |
| Gross Profit | $613K | $638K | $1M | -$285K | $800K |
| Gross Margin | 33.9% | 52.2% | 52.9% | -16.5% | 40.4% |
| R&D Expenses | $1M | $1M | $1M | $970K | $1M |
| SG&A Expenses | $5M | $4M | $4M | $4M | $9M |
| Operating Expenses | $6M | $5M | $5M | $5M | $10M |
| Operating Income | -$6M | -$5M | -$4M | -$5M | -$10M |
| Operating Margin | -320.7% | -375.7% | -209.0% | -283.2% | -480.5% |
| Interest Expense | $5M | $8M | $14M | $10M | $16M |
| Income Before Tax | -$12M | -$16M | -$20M | -$16M | -$29M |
| Tax Expense | -$217K | $0 | $0 | $0 | $0 |
| Net Income | -$12M | -$16M | -$20M | -$16M | -$29M |
| Net Margin | -644.3% | -1311.3% | -1006.5% | -929.6% | -1482.2% |
| EPS (Diluted) | $-7.98 | $-5.32 | $-3.42 | $-1.61 | $-1.51 |
| EBITDA | -$6M | -$7M | -$6M | -$5M | -$9M |
| Shares Outstanding | 2M | 3M | 7M | 11M | 23M |